Role of diffusion-weighted imaging in response prediction and evaluation after high dose rate brachytherapy in patients with colorectal liver metastases

ENETS Centre of Excellence, Interdisciplinary Center of Neuroendocrine Tumours of the GastroEntero-Pancreatic System at the University Hospital of Munich (GEPNET KUM), University Hospital of Munich, Munich, Germany

Jens Ricke

Department of Radiology, University Hospital, LMU Munich, Germany

Regina Schinner

Department of Radiology, University Hospital, LMU Munich, Germany

Karla Treitl

Department of Radiology, University Hospital, LMU Munich, Germany

Johannes Rübenthaler

Department of Radiology, University Hospital, LMU Munich, Germany

Maria Ingenerf

Department of Radiology, University Hospital, LMU Munich, Germany

Christine Schmid-Tannwald

Christine.schmid-tannwald@med.uni-muenchen.de

Department of Radiology, University Hospital, LMU Munich, Germany

Metrics

Articles in this issue

DOI: https://doi.org/10.2478/raon-2024-0017 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099

Journal RSS Feed

Language: English

Page range: 33 - 42

Submitted on: Nov 10, 2023

Accepted on: Jan 4, 2024

Published on: Feb 21, 2024

Published by: Association of Radiology and Oncology

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

liver,

HDR-brachytherapy,

diffusion-weighted imaging,

apparent diffusion coefficient,

colorectal liver metastases

Related subjects:

Medicine,

Clinical medicine,

Internal medicine,

Haematology, oncology,

Radiology

© 2024 Salma Karim, Ricarda Seidensticker, Max Seidensticker, Jens Ricke, Regina Schinner, Karla Treitl, Johannes Rübenthaler, Maria Ingenerf, Christine Schmid-Tannwald, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 58 (2024): Issue 1 (March 2024)